These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The accumulation and metabolism of dopamine by the human platelet. Solomon HM, Spirt NM, Abrams WB. Clin Pharmacol Ther; 1970; 11(6):838-45. PubMed ID: 4394753 [No Abstract] [Full Text] [Related]
6. Modification of the electrokinetic response of blood platelets to aggregating agents. Hampton JR, Mitchell JR. Nature; 1966 Jun 04; 210(5040):1000-2. PubMed ID: 5914884 [No Abstract] [Full Text] [Related]
7. Bovine hepatic fructose 1,6-diphosphatase: modification of the catalytic and allosteric properties by sulfhydryl reagents. Geller AM, Byrne WL. Arch Biochem Biophys; 1972 Dec 04; 153(2):526-36. PubMed ID: 4350806 [No Abstract] [Full Text] [Related]
8. The effect of metabolic inhibitors on the release of vasopressin from the isolated neurohypophysis. Douglas WW, Ishida A, Poisner AM. J Physiol; 1965 Dec 04; 181(4):753-9. PubMed ID: 5881253 [No Abstract] [Full Text] [Related]
9. Uptake and deamination of adenosine by blood. Species differences, effect of pH, ions, temperature and metabolic inhibitors. Van Belle H. Biochim Biophys Acta; 1969 Oct 07; 192(1):124-32. PubMed ID: 5347963 [No Abstract] [Full Text] [Related]
11. Platelet ATPase activities. I. Ecto-ATPases of intact platelets and their possible role in aggregation. Mason RG, Saba SR. Am J Pathol; 1969 May 07; 55(2):215-23. PubMed ID: 4238398 [No Abstract] [Full Text] [Related]